Loss of Homeostasis in the Direct Pathway in a Mouse Model of Asymptomatic Parkinson's Disease

被引:40
|
作者
Escande, Mariela V. [1 ,2 ]
Taravini, Irene R. E. [3 ,4 ,5 ]
Zold, Camila L. [1 ,2 ]
Belforte, Juan E. [1 ,2 ]
Gustavo Murer, M. [1 ,2 ]
机构
[1] Consejo Nacl Invest Cient & Tecn, IFIBIO Bernardo Houssay, Syst Neurosci Grp, RA-1121 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Sch Med, Dept Physiol & Biophys, RA-1121 Buenos Aires, DF, Argentina
[3] Consejo Nacl Invest Cient & Tecn, ININFA, Expt Parkinsonism Grp, RA-1121 Buenos Aires, DF, Argentina
[4] Univ Buenos Aires, RA-1121 Buenos Aires, DF, Argentina
[5] Univ Entre Rios, Expt Neurobiol Lab, RA-2820 Concepcion Del Uruguay, Entre Rios, Argentina
来源
JOURNAL OF NEUROSCIENCE | 2016年 / 36卷 / 21期
关键词
6-OHDA; functional connectivity; in vivo electrophysiology; medium spiny neurons; striatum; STRIATAL PROJECTION NEURONS; MEDIUM SPINY NEURONS; EXTERNAL GLOBUS-PALLIDUS; BAC TRANSGENIC MICE; BASAL GANGLIA; IN-VIVO; STRIATOPALLIDAL NEURONS; L-DOPA; FEEDFORWARD INHIBITION; NIGROSTRIATAL DAMAGE;
D O I
10.1523/JNEUROSCI.0492-15.2016
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The characteristic slowness of movement in Parkinson's disease relates to an imbalance in the activity of striatal medium spiny neurons (MSNs) of the direct (dMSNs) and indirect (iMSNs) pathways. However, it is still unclear whether this imbalance emerges during the asymptomatic phase of the disease or if it correlates with symptom severity. Here, we have used in vivo juxtacellular recordings and transgenic mice showing MSN-type-specific expression of fluorescent proteins to examine striatal imbalance after lesioning dopaminergic neurons of the substantia nigra. Multivariate clustering analysis of behavioral data discriminated 2 groups of dopamine-lesioned mice: asymptomatic (42 +/- 7% dopaminergic neuron loss) and symptomatic (85 +/- 5% cell loss). Contrary to the view that both pathways have similar gain in control conditions, dMSNs respond more intensely than iMSNs to cortical inputs in control animals. Importantly, asymptomatic mice show significant functional disconnection of dMSNs from motor cortex without changes in iMSN connectivity. Moreover, not only the gain but also the timing of the pathways is altered in symptomatic parkinsonism, where iMSNs fire significantly more and earlier than dMSNs. Therefore, cortical drive to dMSNs decreases after partial nigrostriatal lesions producing no behavioral impairment, but additional alterations in the gain and timing of iMSNs characterize symptomatic rodent parkinsonism.
引用
收藏
页码:5686 / 5698
页数:13
相关论文
共 50 条
  • [41] ALTERED SLEEP REGULATION IN A MOUSE MODEL OF PARKINSON'S DISEASE
    Summa, Keith
    Jiang, Peng
    Gonzalez-Rodriguez, Patricia
    Surmeier, James
    Vitaterna, Martha
    Turek, Fred
    SLEEP, 2023, 46 : A115 - A115
  • [42] Proteomic studies on a Parkinson's disease transgenic mouse model
    Voecker, E.
    Nuber, S.
    Meyer, H. E.
    Riess, O.
    Tribl, F.
    Marcus, K.
    JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (03) : VIII - IX
  • [43] Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease
    Zheng, Meizhu
    Liu, Chunming
    Fan, Yajun
    Yan, Pan
    Shi, Dongfang
    Zhang, Yuchi
    NEUROPHARMACOLOGY, 2017, 116 : 412 - 420
  • [44] SNCA multiplication in a new mouse model of Parkinson's disease
    Melrose, H. L.
    Lincoln, S. J.
    Tyndall, G. M.
    Taylor, J. P.
    Dachsel, J. C.
    Yu, X.
    Bass, D.
    Farrer, M. J.
    MOVEMENT DISORDERS, 2006, 21 : S604 - S604
  • [45] Effects of α-synuclein immunization in a mouse model of Parkinson's disease
    Masliah, E
    Rockenstein, E
    Adame, A
    Alford, M
    Crews, L
    Hashimoto, M
    Seubert, P
    Lee, M
    Goldstein, J
    Chilcote, T
    Games, D
    Schenk, D
    NEURON, 2005, 46 (06) : 857 - 868
  • [46] Asymptomatic pulmonary dysfunction in Parkinson's disease
    Arias, M.
    Moris, G.
    Terrero, J. M.
    Navascues, F. A.
    MOVEMENT DISORDERS, 2010, 25 (07) : S352 - S352
  • [47] Osthole Exerts Neuroprotection in a Mouse Model of Parkinson's Disease
    Wang, Shuguang
    Ding, Shilei
    Wang, Yuling
    He, Caiyu
    Yao, Ruiping
    Jin, Hong
    CURRENT TOPICS IN NUTRACEUTICAL RESEARCH, 2023, 21 (01) : 10 - 17
  • [48] Working memory deficits in Parkinson′s disease mouse model
    ZHAO Tingting
    GU Huating
    ZHAO Miao
    CHEN Tianzhi
    AN Yingjie
    ZHANG Xian
    HOU Jincan
    CAO Peng
    ZENG Linghui
    LI Chengyu
    中国药理学与毒理学杂志, 2023, 37 (07) : 517 - 518
  • [49] Sex differences in the MPTP mouse model or Parkinson's disease
    Antzoulatos, E.
    Jakowec, M. W.
    Petzinger, G. M.
    Wood, R. I.
    MOVEMENT DISORDERS, 2008, 23 (01) : S25 - S25
  • [50] A mouse model of Parkinson's Disease based on CoQ deficiency
    Gasser, David L.
    Falk, Marni J.
    Ischiropoulos, Harry
    Bakalar, Dana
    Blendy, Julie A.
    MITOCHONDRION, 2010, 10 (02) : 226 - 226